Covid-19 Impact on Ophthalmic Therapeutics/Drug Market, Global Research Reports 2020-2021
This report covers market size and forecasts of Ophthalmic Therapeutics/Drug, including the following market information:
Major competitors identified in this market include Alcon, Johnson and Johnson Vision Care, Inc., Bausch & Lomb Incorporated, Novartis AG, Merck Sharp & Dohme Corp., Regeneron Pharmaceuticals Inc., Allergan, Pfizer Inc., Valeant, Bayer AG, Santen Pharmaceuticals Co. Ltd, Genentech, Inc., etc.
Based on the Region:
- Global Ophthalmic Therapeutics/Drug Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Ophthalmic Therapeutics/Drug Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Ophthalmic Therapeutics/Drug Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Ophthalmic Therapeutics/Drug Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Major competitors identified in this market include Alcon, Johnson and Johnson Vision Care, Inc., Bausch & Lomb Incorporated, Novartis AG, Merck Sharp & Dohme Corp., Regeneron Pharmaceuticals Inc., Allergan, Pfizer Inc., Valeant, Bayer AG, Santen Pharmaceuticals Co. Ltd, Genentech, Inc., etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- Anti-allergy
- Anti-VEGF Agents
- Anti-inflammatory
- Anti-glaucoma
- Others
- Dry Eye
- Allergies
- Glaucoma
- Infection
- Retinal Disorders
- Uveitis
- Others
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Ophthalmic Therapeutics/Drug Industry
1.7 COVID-19 Impact: Ophthalmic Therapeutics/Drug Market Trends
2 GLOBAL OPHTHALMIC THERAPEUTICS/DRUG QUARTERLY MARKET SIZE ANALYSIS
2.1 Ophthalmic Therapeutics/Drug Business Impact Assessment - COVID-19
2.1.1 Global Ophthalmic Therapeutics/Drug Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Ophthalmic Therapeutics/Drug Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Ophthalmic Therapeutics/Drug Quarterly Market Size, 2019 VS 2020
3.2 By Players, Ophthalmic Therapeutics/Drug Headquarters and Area Served
3.3 Date of Key Players Enter into Ophthalmic Therapeutics/Drug Market
3.4 Key Players Ophthalmic Therapeutics/Drug Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON OPHTHALMIC THERAPEUTICS/DRUG SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Anti-allergy
1.4.2 Anti-VEGF Agents
1.4.3 Anti-inflammatory
1.4.4 Anti-glaucoma
1.4.5 Others
4.2 By Type, Global Ophthalmic Therapeutics/Drug Market Size, 2019-2021
5 IMPACT OF COVID-19 ON OPHTHALMIC THERAPEUTICS/DRUG SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Dry Eye
5.5.2 Allergies
5.5.3 Glaucoma
5.5.4 Infection
5.5.5 Retinal Disorders
5.5.6 Uveitis
5.5.7 Others
5.2 By Application, Global Ophthalmic Therapeutics/Drug Market Size, 2019-2021
5.2.1 By Application, Global Ophthalmic Therapeutics/Drug Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Alcon
7.1.1 Alcon Business Overview
7.1.2 Alcon Ophthalmic Therapeutics/Drug Quarterly Revenue, 2020
7.1.3 Alcon Ophthalmic Therapeutics/Drug Product Introduction
7.1.4 Alcon Response to COVID-19 and Related Developments
7.2 Johnson and Johnson Vision Care, Inc.
7.2.1 Johnson and Johnson Vision Care, Inc. Business Overview
7.2.2 Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Quarterly Revenue, 2020
7.2.3 Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Product Introduction
7.2.4 Johnson and Johnson Vision Care, Inc. Response to COVID-19 and Related Developments
7.3 Bausch & Lomb Incorporated
7.3.1 Bausch & Lomb Incorporated Business Overview
7.3.2 Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Quarterly Revenue, 2020
7.3.3 Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Product Introduction
7.3.4 Bausch & Lomb Incorporated Response to COVID-19 and Related Developments
7.4 Novartis AG
7.4.1 Novartis AG Business Overview
7.4.2 Novartis AG Ophthalmic Therapeutics/Drug Quarterly Revenue, 2020
7.4.3 Novartis AG Ophthalmic Therapeutics/Drug Product Introduction
7.4.4 Novartis AG Response to COVID-19 and Related Developments
7.5 Merck Sharp & Dohme Corp.
7.5.1 Merck Sharp & Dohme Corp. Business Overview
7.5.2 Merck Sharp & Dohme Corp. Ophthalmic Therapeutics/Drug Quarterly Revenue, 2020
7.5.3 Merck Sharp & Dohme Corp. Ophthalmic Therapeutics/Drug Product Introduction
7.5.4 Merck Sharp & Dohme Corp. Response to COVID-19 and Related Developments
7.6 Regeneron Pharmaceuticals Inc.
7.6.1 Regeneron Pharmaceuticals Inc. Business Overview
7.6.2 Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Quarterly Revenue, 2020
7.6.3 Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Product Introduction
7.6.4 Regeneron Pharmaceuticals Inc. Response to COVID-19 and Related Developments
7.7 Allergan
7.7.1 Allergan Business Overview
7.7.2 Allergan Ophthalmic Therapeutics/Drug Quarterly Revenue, 2020
7.7.3 Allergan Ophthalmic Therapeutics/Drug Product Introduction
7.7.4 Allergan Response to COVID-19 and Related Developments
7.8 Pfizer Inc.
7.8.1 Pfizer Inc. Business Overview
7.8.2 Pfizer Inc. Ophthalmic Therapeutics/Drug Quarterly Revenue, 2020
7.8.3 Pfizer Inc. Ophthalmic Therapeutics/Drug Product Introduction
7.8.4 Pfizer Inc. Response to COVID-19 and Related Developments
7.9 Valeant
7.9.1 Valeant Business Overview
7.9.2 Valeant Ophthalmic Therapeutics/Drug Quarterly Revenue, 2020
7.9.3 Valeant Ophthalmic Therapeutics/Drug Product Introduction
7.9.4 Valeant Response to COVID-19 and Related Developments
7.10 Bayer AG
7.10.1 Bayer AG Business Overview
7.10.2 Bayer AG Ophthalmic Therapeutics/Drug Quarterly Revenue, 2020
7.10.3 Bayer AG Ophthalmic Therapeutics/Drug Product Introduction
7.10.4 Bayer AG Response to COVID-19 and Related Developments
7.11 Santen Pharmaceuticals Co. Ltd
7.11.1 Santen Pharmaceuticals Co. Ltd Business Overview
7.11.2 Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics/Drug Quarterly Revenue, 2020
7.11.3 Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics/Drug Product Introduction
7.11.4 Santen Pharmaceuticals Co. Ltd Response to COVID-19 and Related Developments
7.12 Genentech, Inc.
7.12.1 Genentech, Inc. Business Overview
7.12.2 Genentech, Inc. Ophthalmic Therapeutics/Drug Quarterly Revenue, 2020
7.12.3 Genentech, Inc. Ophthalmic Therapeutics/Drug Product Introduction
7.12.4 Genentech, Inc. Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Ophthalmic Therapeutics/Drug Industry
1.7 COVID-19 Impact: Ophthalmic Therapeutics/Drug Market Trends
2 GLOBAL OPHTHALMIC THERAPEUTICS/DRUG QUARTERLY MARKET SIZE ANALYSIS
2.1 Ophthalmic Therapeutics/Drug Business Impact Assessment - COVID-19
2.1.1 Global Ophthalmic Therapeutics/Drug Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Ophthalmic Therapeutics/Drug Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Ophthalmic Therapeutics/Drug Quarterly Market Size, 2019 VS 2020
3.2 By Players, Ophthalmic Therapeutics/Drug Headquarters and Area Served
3.3 Date of Key Players Enter into Ophthalmic Therapeutics/Drug Market
3.4 Key Players Ophthalmic Therapeutics/Drug Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON OPHTHALMIC THERAPEUTICS/DRUG SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Anti-allergy
1.4.2 Anti-VEGF Agents
1.4.3 Anti-inflammatory
1.4.4 Anti-glaucoma
1.4.5 Others
4.2 By Type, Global Ophthalmic Therapeutics/Drug Market Size, 2019-2021
5 IMPACT OF COVID-19 ON OPHTHALMIC THERAPEUTICS/DRUG SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Dry Eye
5.5.2 Allergies
5.5.3 Glaucoma
5.5.4 Infection
5.5.5 Retinal Disorders
5.5.6 Uveitis
5.5.7 Others
5.2 By Application, Global Ophthalmic Therapeutics/Drug Market Size, 2019-2021
5.2.1 By Application, Global Ophthalmic Therapeutics/Drug Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Alcon
7.1.1 Alcon Business Overview
7.1.2 Alcon Ophthalmic Therapeutics/Drug Quarterly Revenue, 2020
7.1.3 Alcon Ophthalmic Therapeutics/Drug Product Introduction
7.1.4 Alcon Response to COVID-19 and Related Developments
7.2 Johnson and Johnson Vision Care, Inc.
7.2.1 Johnson and Johnson Vision Care, Inc. Business Overview
7.2.2 Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Quarterly Revenue, 2020
7.2.3 Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Product Introduction
7.2.4 Johnson and Johnson Vision Care, Inc. Response to COVID-19 and Related Developments
7.3 Bausch & Lomb Incorporated
7.3.1 Bausch & Lomb Incorporated Business Overview
7.3.2 Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Quarterly Revenue, 2020
7.3.3 Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Product Introduction
7.3.4 Bausch & Lomb Incorporated Response to COVID-19 and Related Developments
7.4 Novartis AG
7.4.1 Novartis AG Business Overview
7.4.2 Novartis AG Ophthalmic Therapeutics/Drug Quarterly Revenue, 2020
7.4.3 Novartis AG Ophthalmic Therapeutics/Drug Product Introduction
7.4.4 Novartis AG Response to COVID-19 and Related Developments
7.5 Merck Sharp & Dohme Corp.
7.5.1 Merck Sharp & Dohme Corp. Business Overview
7.5.2 Merck Sharp & Dohme Corp. Ophthalmic Therapeutics/Drug Quarterly Revenue, 2020
7.5.3 Merck Sharp & Dohme Corp. Ophthalmic Therapeutics/Drug Product Introduction
7.5.4 Merck Sharp & Dohme Corp. Response to COVID-19 and Related Developments
7.6 Regeneron Pharmaceuticals Inc.
7.6.1 Regeneron Pharmaceuticals Inc. Business Overview
7.6.2 Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Quarterly Revenue, 2020
7.6.3 Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Product Introduction
7.6.4 Regeneron Pharmaceuticals Inc. Response to COVID-19 and Related Developments
7.7 Allergan
7.7.1 Allergan Business Overview
7.7.2 Allergan Ophthalmic Therapeutics/Drug Quarterly Revenue, 2020
7.7.3 Allergan Ophthalmic Therapeutics/Drug Product Introduction
7.7.4 Allergan Response to COVID-19 and Related Developments
7.8 Pfizer Inc.
7.8.1 Pfizer Inc. Business Overview
7.8.2 Pfizer Inc. Ophthalmic Therapeutics/Drug Quarterly Revenue, 2020
7.8.3 Pfizer Inc. Ophthalmic Therapeutics/Drug Product Introduction
7.8.4 Pfizer Inc. Response to COVID-19 and Related Developments
7.9 Valeant
7.9.1 Valeant Business Overview
7.9.2 Valeant Ophthalmic Therapeutics/Drug Quarterly Revenue, 2020
7.9.3 Valeant Ophthalmic Therapeutics/Drug Product Introduction
7.9.4 Valeant Response to COVID-19 and Related Developments
7.10 Bayer AG
7.10.1 Bayer AG Business Overview
7.10.2 Bayer AG Ophthalmic Therapeutics/Drug Quarterly Revenue, 2020
7.10.3 Bayer AG Ophthalmic Therapeutics/Drug Product Introduction
7.10.4 Bayer AG Response to COVID-19 and Related Developments
7.11 Santen Pharmaceuticals Co. Ltd
7.11.1 Santen Pharmaceuticals Co. Ltd Business Overview
7.11.2 Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics/Drug Quarterly Revenue, 2020
7.11.3 Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics/Drug Product Introduction
7.11.4 Santen Pharmaceuticals Co. Ltd Response to COVID-19 and Related Developments
7.12 Genentech, Inc.
7.12.1 Genentech, Inc. Business Overview
7.12.2 Genentech, Inc. Ophthalmic Therapeutics/Drug Quarterly Revenue, 2020
7.12.3 Genentech, Inc. Ophthalmic Therapeutics/Drug Product Introduction
7.12.4 Genentech, Inc. Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Ophthalmic Therapeutics/Drug Assessment
Table 9. COVID-19 Impact: Ophthalmic Therapeutics/Drug Market Trends
Table 10. COVID-19 Impact Global Ophthalmic Therapeutics/Drug Market Size
Table 11. Global Ophthalmic Therapeutics/Drug Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Ophthalmic Therapeutics/Drug Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Ophthalmic Therapeutics/Drug Market Growth Drivers
Table 14. Global Ophthalmic Therapeutics/Drug Market Restraints
Table 15. Global Ophthalmic Therapeutics/Drug Market Opportunities
Table 16. Global Ophthalmic Therapeutics/Drug Market Challenges
Table 17. By Players, Ophthalmic Therapeutics/Drug Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Ophthalmic Therapeutics/Drug Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Ophthalmic Therapeutics/Drug Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Ophthalmic Therapeutics/Drug Market
Table 21. Key Players Ophthalmic Therapeutics/Drug Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Ophthalmic Therapeutics/Drug Market Size 2019-2021, (US$ Million)
Table 24. Global Ophthalmic Therapeutics/Drug Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Ophthalmic Therapeutics/Drug Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 57. Alcon Business Overview
Table 58. Alcon Ophthalmic Therapeutics/Drug Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Alcon Ophthalmic Therapeutics/Drug Product
Table 60. Alcon Response to COVID-19 and Related Developments
Table 61. Johnson and Johnson Vision Care, Inc. Business Overview
Table 62. Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Product
Table 64. Johnson and Johnson Vision Care, Inc. Response to COVID-19 and Related Developments
Table 65. Bausch & Lomb Incorporated Business Overview
Table 66. Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Product
Table 68. Bausch & Lomb Incorporated Response to COVID-19 and Related Developments
Table 69. Novartis AG Business Overview
Table 70. Novartis AG Ophthalmic Therapeutics/Drug Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Novartis AG Ophthalmic Therapeutics/Drug Product
Table 72. Novartis AG Response to COVID-19 and Related Developments
Table 73. Merck Sharp & Dohme Corp. Business Overview
Table 74. Merck Sharp & Dohme Corp. Ophthalmic Therapeutics/Drug Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Merck Sharp & Dohme Corp. Ophthalmic Therapeutics/Drug Product
Table 76. Merck Sharp & Dohme Corp. Response to COVID-19 and Related Developments
Table 77. Regeneron Pharmaceuticals Inc. Business Overview
Table 78. Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Product
Table 80. Regeneron Pharmaceuticals Inc. Response to COVID-19 and Related Developments
Table 81. Allergan Business Overview
Table 82. Allergan Ophthalmic Therapeutics/Drug Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Allergan Ophthalmic Therapeutics/Drug Product
Table 84. Allergan Response to COVID-19 and Related Developments
Table 85. Pfizer Inc. Business Overview
Table 86. Pfizer Inc. Ophthalmic Therapeutics/Drug Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Pfizer Inc. Ophthalmic Therapeutics/Drug Product
Table 88. Pfizer Inc. Response to COVID-19 and Related Developments
Table 89. Valeant Business Overview
Table 90. Valeant Ophthalmic Therapeutics/Drug Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Valeant Ophthalmic Therapeutics/Drug Product
Table 92. Valeant Response to COVID-19 and Related Developments
Table 93. Bayer AG Business Overview
Table 94. Bayer AG Ophthalmic Therapeutics/Drug Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Bayer AG Ophthalmic Therapeutics/Drug Product
Table 96. Bayer AG Response to COVID-19 and Related Developments
Table 97. Santen Pharmaceuticals Co. Ltd Business Overview
Table 98. Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics/Drug Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics/Drug Product
Table 100. Santen Pharmaceuticals Co. Ltd Response to COVID-19 and Related Developments
Table 101. Genentech, Inc. Business Overview
Table 102. Genentech, Inc. Ophthalmic Therapeutics/Drug Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. Genentech, Inc. Ophthalmic Therapeutics/Drug Product
Table 104. Genentech, Inc. Response to COVID-19 and Related Developments
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Ophthalmic Therapeutics/Drug Assessment
Table 9. COVID-19 Impact: Ophthalmic Therapeutics/Drug Market Trends
Table 10. COVID-19 Impact Global Ophthalmic Therapeutics/Drug Market Size
Table 11. Global Ophthalmic Therapeutics/Drug Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Ophthalmic Therapeutics/Drug Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Ophthalmic Therapeutics/Drug Market Growth Drivers
Table 14. Global Ophthalmic Therapeutics/Drug Market Restraints
Table 15. Global Ophthalmic Therapeutics/Drug Market Opportunities
Table 16. Global Ophthalmic Therapeutics/Drug Market Challenges
Table 17. By Players, Ophthalmic Therapeutics/Drug Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Ophthalmic Therapeutics/Drug Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Ophthalmic Therapeutics/Drug Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Ophthalmic Therapeutics/Drug Market
Table 21. Key Players Ophthalmic Therapeutics/Drug Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Ophthalmic Therapeutics/Drug Market Size 2019-2021, (US$ Million)
Table 24. Global Ophthalmic Therapeutics/Drug Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Ophthalmic Therapeutics/Drug Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Ophthalmic Therapeutics/Drug Market Size, 2019-2021 (US$ Million)
Table 57. Alcon Business Overview
Table 58. Alcon Ophthalmic Therapeutics/Drug Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Alcon Ophthalmic Therapeutics/Drug Product
Table 60. Alcon Response to COVID-19 and Related Developments
Table 61. Johnson and Johnson Vision Care, Inc. Business Overview
Table 62. Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Product
Table 64. Johnson and Johnson Vision Care, Inc. Response to COVID-19 and Related Developments
Table 65. Bausch & Lomb Incorporated Business Overview
Table 66. Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Product
Table 68. Bausch & Lomb Incorporated Response to COVID-19 and Related Developments
Table 69. Novartis AG Business Overview
Table 70. Novartis AG Ophthalmic Therapeutics/Drug Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Novartis AG Ophthalmic Therapeutics/Drug Product
Table 72. Novartis AG Response to COVID-19 and Related Developments
Table 73. Merck Sharp & Dohme Corp. Business Overview
Table 74. Merck Sharp & Dohme Corp. Ophthalmic Therapeutics/Drug Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Merck Sharp & Dohme Corp. Ophthalmic Therapeutics/Drug Product
Table 76. Merck Sharp & Dohme Corp. Response to COVID-19 and Related Developments
Table 77. Regeneron Pharmaceuticals Inc. Business Overview
Table 78. Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Product
Table 80. Regeneron Pharmaceuticals Inc. Response to COVID-19 and Related Developments
Table 81. Allergan Business Overview
Table 82. Allergan Ophthalmic Therapeutics/Drug Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Allergan Ophthalmic Therapeutics/Drug Product
Table 84. Allergan Response to COVID-19 and Related Developments
Table 85. Pfizer Inc. Business Overview
Table 86. Pfizer Inc. Ophthalmic Therapeutics/Drug Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Pfizer Inc. Ophthalmic Therapeutics/Drug Product
Table 88. Pfizer Inc. Response to COVID-19 and Related Developments
Table 89. Valeant Business Overview
Table 90. Valeant Ophthalmic Therapeutics/Drug Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Valeant Ophthalmic Therapeutics/Drug Product
Table 92. Valeant Response to COVID-19 and Related Developments
Table 93. Bayer AG Business Overview
Table 94. Bayer AG Ophthalmic Therapeutics/Drug Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Bayer AG Ophthalmic Therapeutics/Drug Product
Table 96. Bayer AG Response to COVID-19 and Related Developments
Table 97. Santen Pharmaceuticals Co. Ltd Business Overview
Table 98. Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics/Drug Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics/Drug Product
Table 100. Santen Pharmaceuticals Co. Ltd Response to COVID-19 and Related Developments
Table 101. Genentech, Inc. Business Overview
Table 102. Genentech, Inc. Ophthalmic Therapeutics/Drug Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. Genentech, Inc. Ophthalmic Therapeutics/Drug Product
Table 104. Genentech, Inc. Response to COVID-19 and Related Developments
LIST OF FIGURES
Figure 1. Ophthalmic Therapeutics/Drug Product Picture
Figure 2. Ophthalmic Therapeutics/Drug Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Ophthalmic Therapeutics/Drug Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Ophthalmic Therapeutics/Drug Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Ophthalmic Therapeutics/Drug Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Ophthalmic Therapeutics/Drug Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Ophthalmic Therapeutics/Drug Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Ophthalmic Therapeutics/Drug Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Ophthalmic Therapeutics/Drug Market Size Market Share, 2019-2021
Figure 1. Ophthalmic Therapeutics/Drug Product Picture
Figure 2. Ophthalmic Therapeutics/Drug Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Ophthalmic Therapeutics/Drug Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Ophthalmic Therapeutics/Drug Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Ophthalmic Therapeutics/Drug Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Ophthalmic Therapeutics/Drug Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Ophthalmic Therapeutics/Drug Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Ophthalmic Therapeutics/Drug Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Ophthalmic Therapeutics/Drug Market Size Market Share, 2019-2021
